Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I meant a 1 share AMRN for one share AMGN. Thats what V is worth AT LEAST
I sure hope youre wrong. $30 would be a huge disappointment. The only way I would settle for $30 would be a BO from somebody like AMGN on a 1:1 share trade
Yes thats what he ssid. I couldnt believe it. I would have fired him on the spot. He must be the boss’s kid
Yes I was paying close attention. That was a smart move
Yes I heard that and I agree. Its just that I spent 45 years in sales and realize the need for an articulate effective communicator
Good content. His delivery is an ongoing problem
I agree. I would rather have an articulate sales charismatic sales oriented spokesperson as I have stated here repeatedly. Make me look stupid today JT!!
He belongs in prison
Good work. A mid-May announcement by the FDA would be fantastic. Very realistic
$100 by June?? Unless Forbes decides to do another hit piece. I woner if AMRN legal dept ever gave them a call?? I sure hope so
John Najarian was a famous transplant surgeon at the University of Minnesota where his son Pete was a pretty good football player for the Gophers
IF it was to be Amgen- how about a 1 for 1 stock trade?? $35 doesnt do anything for me.
Yeah baby! Bring it on. AMRN is the most oversold stock on the market. We KNOW what we have.
Its all perception- somebody thinks somebody “knows something”. BO talk is good for PPS in the short term. Thise of us longs and particularly those of us who have been on V for a while REALLY KNOW SOMETHING
Obviously I want to target Docs which is why they hired 400 reps but the investing public needs to hear the Reduce -It story. The current commercials are useless. We need to kerp the PPS up. Its sinking big time
If AMRN is truly going to GIA then a VP Director of Marketing who is a top shelf heavy hitter is the first order of business Someone who can go on CNBC et al and communicate to the world what we truly have with V. If not PPS is going sideways and downward
Perhaps the reason to put out $350mil is to get BPs to say “let us have it, we’ll do double that in 19”. And then it begins??
Jt knows we have a marvelous game changer drug. Smart BP knows it. The PPS is ridiculously low. I have to believe BO offers have been multiple. V is golden. Everyone who has been taking it knows it. The PPS doesnt compute. The investing public is obviously unaware
A better question is what will PPS be on Jan 1 2020 ?? Will there even be an AMRN?? I want to retire yhis year so be need a major move upward for me to do so. We have a great drug- the world needs it but so far they dont know about it for various reasons. I am beginning to think BP wants the PPS this low do they can buy AMRN cheaper. So far its working
Lets face it- JT and Baker Brothers will ultimately decide what gives the shareholders the best bang for our long held shares. BB doesnt necessarily like the PPS anymore than we do unless they are accumulating more. Who knows?
$11.78 was the bottom or do I exaggerate?Talk about a stock being oversold.
V is too good to fail. One way or another- BO or not - we have a real winner here
So much for the $13.50 support. What is the bottom??JT needs to throw us a bone before Jan1. A teaser- anything!
Like we have discussed in person with each other- it’s called Marketing!! Lets see some! We have a life changing product!! Let the world hear about it. I guess I would have to agree with you that the silence from AMRN may mean partner/BO is in the works. Otherwise- why so quiet?
Enormous buy at the bell-574k— Anybody we know?
Enormous buy at the bell 574k!! Anybody we know ?
I would be ery interested to hear some particulars on these two BOs like PPS ? Cash stock buyout?
Jefferies Investment Banking Products:
Debt Capital Markets
Equity Capital Markets
Mergers & Acquisitions
Private Capital Advisory
Restructuring & Recapitalization Hmmmmmmm
Cheer up- you could be a Vikings fan for the last 58 years like me. The Vikings are a doomed franchise- congential losers
Day traders are keeping PPS under $17. The volume has been extremely low for days now. We need a jolt. Cmon JT- throw us a bone. Im trying to tell everyone I know including Docs my pharmacist etc. Even my CPA invested in AMRN-he’s not too happy buying in at $20. - I thought this patience thing would be over by now. Some of you long timers must be full of virtue.
I am still not convinced that the bear attack after AHA was not orchestrated by BP to lowball and/or a hostile takeover BP knows what V is worth- the market obviously does not
This guy cost me $6 figures after he wrote his hit piece on R-I. I wonder if he has heard from AMRNs lawyers?? I sure hope so
Yes I heard that. He has at least now acknowledged that a BO MIGHT be better for the shareholders
Yes I agree. Its AMRN’s job to do this. The word has to get out and $17 PPS says it hasnt so far. Does AMRN have a plan B ??Plan A didnt work
True. Without some sort of announcement the PPS is locked in $17-18 range. 70 days after topline results and nearly a month after AHA and we are down and sideways at best. Very disappointing
Preach it brother- I love it. After a 48 year sales career I can honestly say that I wish I could have had a product like V to sell!
The CC call was strictly ho hum. AMRN needs a dynamic spokesman. JL is strictly a bean counter good with techical talk but as far as PR -not so much. This stock at $17 is a joke. For us longs- this is going to be really long unless the market comes to know what we know. They obviously dont. We need to hear about a European partner before Jan 1 or this stock is drifting downward and sideways
Youre right. I get the same feeling everytime I see him. Im glad he is the CEO but he isnt the man to get the message out on CNBC for instance. Salesmanship goes a long way and V is the real deal so who can tell the world about it effectively??
What I have learned after 45 years in sales is that some companies have great products but no vison on how to market them. Other companies have mediocre to poor products but know about marketing and sales and are very successful. I think AMRN needs some matketing help big time. Some screwball piece in Forbes has the PPS at $17 when it should be double that price. Am I plausible or do I exaggerate??
I agree. He cimes across as a bean counter to me -smart but not charismatic